Celldex Therapeutics
CLDX
$36.30
Share price
0.11%
Change (1 day)
12.28%
Change (1 year)
Categories
Celldex Therapeutics (CLDX) - Cash on Hand
Cash on Hand as of December 2023 : $0.42 B
According to Celldex Therapeutics's latest financial reports the company has $0.42 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Celldex Therapeutics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.42 B | 38.91% |
| 2022-12-31 | $0.30 B | -25.3% |
| 2021-12-31 | $0.40 B | 109.98% |
| 2020-12-31 | $0.19 B | 201.98% |
| 2019-12-31 | $64.38 M | -31.52% |
| 2018-12-31 | $94.02 M | -32.57% |
| 2017-12-31 | $0.13 B | -26.53% |
| 2016-12-31 | $0.18 B | -34.53% |
| 2015-12-31 | $0.28 B | 44.19% |
| 2014-12-31 | $0.20 B | -33.65% |
| 2013-12-31 | $0.30 B | 260.86% |
| 2012-12-31 | $83.96 M | 57.49% |
| 2011-12-31 | $53.31 M | -12.74% |
| 2010-12-31 | $61.09 M | -25.9% |
| 2009-12-31 | $82.45 M | 86.3% |
| 2008-12-31 | $44.25 M | 801.45% |
| 2007-12-31 | $4.9 M | -88% |
| 2006-12-31 | $40.91 M | 74.69% |
| 2005-12-31 | $23.41 M | -26.22% |
| 2004-12-31 | $31.74 M | 56.74% |
| 2003-12-31 | $20.25 M | -19.22% |
| 2002-12-31 | $25.07 M | -41.24% |
| 2001-12-31 | $42.66 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $12.69 B | 2,895.76% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 2,483.58% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.35 B | 1,400.20% | 🇬🇧 UK |
 Titan Pharmaceuticals
TTNP | $8.09 M | -98.09% | 🇺🇸 USA |
 Seagen
SGEN | $1.23 B | 192.02% | 🇺🇸 USA |
 Agenus
AGEN | $76.11 M | -82.03% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.11 B | -73.63% | 🇺🇸 USA |